Smoking Cessation Intervention for Thoracic Patients

Completed · Phase 1/Phase 2

Conditions studied: Lung Cancer

In brief

The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.

Key facts

Study ID

NCT00580398

Run by

Massachusetts General Hospital

People needed

49

Starts

2008-01-01

Expected to finish

2012-04-01

Last updated by the study team

2018-10-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A patient is eligible if he/she:
• Is scheduled for a lung resection surgery with either a lung cancer diagnosis or a potential lung cancer diagnosis
• Smoked a cigarette in the past 2 weeks
• Is willing to make a pre-surgical quit attempt

You may not qualify if…

• Patients will be excluded from the intervention group if they are:
• Non-English speaking
• Determined medically ineligible by their surgeon
• Suffering from psychosis or dementia
• Have been taking Varenicline for longer than three weeks
• Have been taking Bupropion (for smoking cessation purposes) for more than three weeks
• Is otherwise unable to participate in the intervention.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.